• Chronic urticaria and inflammatory bowel disease — is it worth looking further?
en To content Full text of article

Chronic urticaria and inflammatory bowel disease — is it worth looking further?

Modern Pediatrics. Ukraine. (2021). 6(118): 55-60. doi 10.15574/SP.2021.118.55
Okhotnikova O. M.1, Romanchuk A. A.1, Grishchenko O. M.2
1Shupyk National Healthcare University of Ukraine, Kyiv
2National Children's Specialized Hospital «OKHMATDYT», Kyiv, Ukraine

For citation: Okhotnikova OM, Romanchuk AA, Grishchenko OM. (2021). Chronic urticaria and inflammatory bowel disease — is it worth looking further? Modern Pediatrics. Ukraine. 6(118): 55-60. doi 10.15574/SP.2021.118.55.
Article received: Jul 07, 2021. Accepted for publication: Oct 09, 2021.

Chronic urticaria is a common disease that also occurs against the background of inflammatory bowel disease. This case draws attention to the common pathophysiology between autoimmune and autoinflammatory diseases and the need for careful differential diagnosis and further research, which can significantly influence the choice of treatment tactics.
Clinical case. An 9-year-old girl with chronic urticaria from birth and recurrent episodes of fever and conjunctivitis was examined at the pediatric ward of the National Children's Specialized Hospital «OKHMATDYT». On the basis of negative results of determination of serum level of immunoglobulins A to gliadin and endomysia celiac disease is excluded, and also by means of modern methods of allergodiagnostics (skin prick-tests, cold test, molecular allergodiagnostics, elimination dietodiagnostics) influence of various is excluded. The girl was diagnosed with chronic idiopathic urticaria with inflammatory bowel disease with trial treatment with ketatifen, bilastine and mesalazine. Due to complaints of recurrent rashes and fever on the background of this therapy, the anamnesis of the disease was re-analyzed and the material was sent for genetic sequencing, which allowed to change the diagnosis to auto-inflammatory disease and prescribed therapy — daily administration of anakinra. Since then, she no longer has recurrent febrile fever or urticaria, and the level of markers of inflammation has returned to normal.
Conclusions. This clinical example is interesting for a complex diagnostic search, when a combination of chronic urticaria and inflammatory bowel disease was observed without effect on therapy, which forced to reconsider the diagnosis, which turned out to be even rarer and was finally confirmed by genome sequencing. But despite the fact that the diagnosis was different, it is interesting that on the background of taking mesalazine the girl's condition still improved slightly: became less likely to bother urticarial rash and fever on the background of the rash, which may indicate some common pathogenetic features of inflammation in intestines and chronic idiopathic urticaria, which has an indisputable scientific and practical interest.
The research was carried out in accordance with the principles of the Helsinki declaration. The informed consent of the patient was obtained for conducting the studies.
No conflict of interest was declared by the authors.
Key words: urticaria, inflammatory bowel disease, autoinflammatory diseases, interleukinE1, Biologics, anakinra.

REFERENCES

1. Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y. (2008). Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol. 14: 5154-5161. https://doi.org/10.3748/wjg.14.5154; PMid:18777592 PMCid:PMC2744005

2. Banerji A, Sheffer AL. (2009). The spectrum of chronic angioedema. Allergy Asthma Proc. 30: 11-16. https://doi.org/10.2500/aap.2009.30.3188; PMid:19331715

3. Bene L, Falus A, Baffy N, Fulop AK. (2011). Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease. PatholOncolRes. 17: 463-472. https://doi.org/10.1007/s12253-011-9397-4; PMid:21681604

4. Burak KW, May GR. (2000). C1 inhibitor deficiency and angioedema of the small intestine masquerading as Crohn's disease. Can J Gastroenterol. 14: 349-451. https://doi.org/10.1155/2000/414107; PMid:10799090

5. Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L, Ghirardello A, Iaccarino L, Punzi L. (2012). Autoinflammation and autoimmunity: bridging the divide. Autoimmun. Rev. 12: 22-30. https://doi.org/10.1016/j.autrev.2012.07.018; PMid:22878274

6. Dos Santos JC, Azor MH, Nojima VY, Lourenco FD, Prearo E, Maruta CW, Rivitti EA, da Silva Duarte AJ, Sato MN. (2008). Increased circulating proinflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int Immunopharmacol. 8: 1433-1440. https://doi.org/10.1016/j.intimp.2008.05.016; PMid:18586117

7. Farkas H, Gyeney L, Nemesanszky E, Kaldi G, Kukan F, Masszi I, Soos J, Bely M, Farkas E, Fust G et al. (1999). Coincidence of hereditary angioedema (HAE) with Crohn's disease. Immunol Invest. 28: 43-53. https://doi.org/10.3109/08820139909022722; PMid:10073681

8. Freeman HJ. (2000). Hereditary angioneurotic edema and familial Crohn's disease. Can J Gastroenterol. 14: 337-339. https://doi.org/10.1155/2000/828679; PMid:10799088

9. Habal F, Huang V. (2012). Angioedema associated with Crohn's disease: Response to biologics. World J Gastroenterol. 18 (34): 4787-4790. https://doi.org/10.3748/wjg.v18.i34.4787; PMid:23002350 PMCid:PMC3442219

10. Hermes B, Prochazka AK, Haas N, Jurgovsky K, Sticherling M, Henz BM. (1999). Upregulation of TNF-α and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol. 103: 307-314. https://doi.org/10.1016/S0091-6749(99)70506-3

11. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. (2011). Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 140: 957-965. https://doi.org/10.1053/j.gastro.2010.12.002; PMid:21147109 PMCid:PMC3049831

12. Kaplan AP, Greaves M. (2009). Pathogenesis of chronic urticaria. Clin Exp Allergy. 39: 777-787. https://doi.org/10.1111/j.1365-2222.2009.03256.x; PMid:19400905

13. Malcolm A, Prather CM. (1999). Intestinal angioedema mimicking Crohn's disease. Med J Aust. 171: 418-420. https://doi.org/10.5694/j.1326-5377.1999.tb123722.x; PMid:10590745

14. Mansueto P, Carroccio A, Corsale S, Di Lorenzo G, Di Prima L, Pirrone G, Florena AM, Di Fede G. (2009). Chronic urticaria as a presenting symptom of Crohn's disease. BMJ Case Rep. Epub ahead of print. https://doi.org/10.1136/bcr.08.2008.0781; PMid:21897833 PMCid:PMC3028168

15. McGonagle D, MF. (2006). McDermott. A proposed classification of the immunological diseases. PLoSMed. 3: 297. https://doi.org/10.1371/journal.pmed.0030297; PMid:16942393 PMCid:PMC1564298

16. Naimeh LG, Muller BA. (2001). Chronic urticaria in a 17-year-old patient with a past history of bowel disease. Ann Allergy Asthma Immunol. 86: 511-516. https://doi.org/10.1016/S1081-1206(10)62898-0

17. Navegantes KC, de Souza Gomes R, Pereira PAT, Czaikoski PG, Azevedo CHM, Monteiro MC. (2017). Immune modulation of some autoimmune dis-eases: the critical role of macrophages and neutrophils in the innate and adaptiveimmunity. J Transl Med. 15: 36. https://doi.org/10.1186/s12967-017-1141-8; PMid:28202039 PMCid:PMC5312441

18. Okhotnikova OM, Mellina KV. (2015). Kropyvianka ta anhionabriak u ditei. Klinichna imunolohiia. Alerholohiia. Infektolohiia. 1 (80): 5-15.

19. Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF. (2008). Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet. 372: 67-81. https://doi.org/10.1016/S0140-6736(08)60995-2

20. Philpott H, Kette F, Hissaria P, Gillis D, Smith W. (2008). Chronic urticaria: the autoimmune paradigm. Intern Med J. 38: 852-857. https://doi.org/10.1111/j.1445-5994.2008.01673.x; PMid:19120535

21. Strober W, Fuss IJ. (2011). Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 140: 1756-1767. https://doi.org/10.1053/j.gastro.2011.02.016; PMid:21530742 PMCid:PMC3773507

22. Touitou I, Aksentijevich I. (2019). Genetic approach to the diagnosis of autoin-flammatory diseases, in: Hashkes P.J., Laxer R.M., Simon A. Textb. Autoinflammation. Springer International Publishing. Cham: 225-237. https://doi.org/10.1007/978-3-319-98605-0_12

23. Twilt M, Benseler SM. (2019). Cryopyrin-Associated Periodic Syndromes (CAPS). In: Efthimiou P. Auto-Inflammatory Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-96929-9_8

24. Waldner H. (2009). The role of innate immune responses in autoimmune disease development. Autoimmun. Rev. 8: 400-404. https://doi.org/10.1016/j.autrev.2008.12.019; PMid:19162250

25. Wang L, Wang FS, ME. (2015). Gershwin. Human autoimmune diseases: a compre-hensive update. J Intern Med. 278: 369-395. https://doi.org/10.1111/joim.12395; PMid:26212387